TBPH Theravance Biopharma, Inc.

NASDAQ
$17.03

Theravance Biopharma, Inc. (TBPH) Institutional Ownership

What the institutions did with TBPH last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
204
filed a 13F this quarter
Managers holding
178
+8 on the quarter
Buyers
98
34 opened new
Sellers
80
26 sold out entirely
Buyer share
55.1%
of managers who traded it
Breadth
+10.1
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Madison Avenue Partners, LP 9.2M 19.2%
Weiss Asset Management LP 7.5M 15.5%
BlackRock, Inc. 4.6M 9.5%
Newtyn Management, LLC 3.4M 7.1%
Irenic Capital Management LP 2.8M 5.7%
VANGUARD CAPITAL MANAGEMENT LLC 1.8M 3.7%
STATE STREET CORP 1.3M 2.8%
TWO SIGMA INVESTMENTS, LP 1.2M 2.5%
D. E. Shaw & Co., Inc. 1.2M 2.5%
ACADIAN ASSET MANAGEMENT LLC 1.2M 2.4%
GEODE CAPITAL MANAGEMENT, LLC 1.1M 2.3%
DIMENSIONAL FUND ADVISORS LP 1.0M 2.2%
MACKENZIE FINANCIAL CORP 985.8K 2.0%
MORGAN STANLEY 705.2K 1.5%
Oasis Management Co Ltd. 583.5K 1.2%
CITADEL ADVISORS LLC 506.7K 1.1%
UBS Group AG 488.3K 1.0%
Qube Research & Technologies Ltd 429.8K 0.9%
NORTHERN TRUST CORP 404.4K 0.8%
VANGUARD PORTFOLIO MANAGEMENT LLC 394.2K 0.8%
Jupiter Topco LLC 387.5K 0.8%
GOLDMAN SACHS GROUP INC 340.0K 0.7%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 321.2K 0.7%
GLAZER CAPITAL, LLC 301.8K 0.6%
VANGUARD FIDUCIARY TRUST CO 272.2K 0.6%

Largest changes

Manager Action Previous Current Change
Newtyn Management, LLC Reduced 4.8M 3.4M -1.4M
MACKENZIE FINANCIAL CORP Increased 248.7K 985.8K +737.2K
CITADEL ADVISORS LLC Increased 86.1K 506.7K +420.6K
Assenagon Asset Management S.A. Sold Out 404.1K 0 -404.1K
Invesco Ltd. Reduced 409.4K 75.4K -334.1K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Sold Out 327.5K 0 -327.5K
GLAZER CAPITAL, LLC New 0 301.8K +301.8K
Madison Avenue Partners, LP Reduced 9.5M 9.2M -298.9K
Pacer Advisors, Inc. Sold Out 293.2K 0 -293.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced 341.6K 57.5K -284.1K
UBS Group AG Reduced 764.1K 488.3K -275.8K
BlackRock, Inc. Increased 4.3M 4.6M +266.2K
683 Capital Management, LLC Sold Out 250.0K 0 -250.0K
D. E. Shaw & Co., Inc. Increased 954.0K 1.2M +231.3K
MORGAN STANLEY Increased 510.3K 705.2K +194.9K
Caption Management, LLC Sold Out 163.7K 0 -163.7K
HRT FINANCIAL LP Reduced 328.7K 180.6K -148.0K
Qube Research & Technologies Ltd Increased 289.5K 429.8K +140.3K
Trexquant Investment LP Reduced 205.8K 76.5K -129.3K
WEDGE CAPITAL MANAGEMENT L L P/NC New 0 128.8K +128.8K
BANK OF AMERICA CORP /DE/ Reduced 189.2K 73.7K -115.5K
MILLENNIUM MANAGEMENT LLC New 0 115.4K +115.4K
Verition Fund Management LLC Sold Out 110.0K 0 -110.0K
Schonfeld Strategic Advisors LLC New 0 108.9K +108.9K
ACADIAN ASSET MANAGEMENT LLC Reduced 1.3M 1.2M -101.7K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.